The rs1800629 polymorphism in the TNF gene interacts with physical activity on the changes in C-reactive protein levels in the Finnish Diabetes Prevention Study
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
The rs1800629 polymorphism in the TNF gene interacts with physical activity on the changes in C-reactive protein levels in the Finnish Diabetes Prevention Study. / Oskari Kilpeläinen, Tuomas; Laaksonen, D E; Lakka, T A; Herder, C; Koenig, W; Lindström, J; Eriksson, J G; Uusitupa, M; Kolb, H; Laakso, M; Tuomilehto, J; Finnish Diabetes Prevention Study.
In: Experimental and Clinical Endocrinology and Diabetes, Vol. 118, No. 10, 11.2010, p. 757-9.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The rs1800629 polymorphism in the TNF gene interacts with physical activity on the changes in C-reactive protein levels in the Finnish Diabetes Prevention Study
AU - Oskari Kilpeläinen, Tuomas
AU - Laaksonen, D E
AU - Lakka, T A
AU - Herder, C
AU - Koenig, W
AU - Lindström, J
AU - Eriksson, J G
AU - Uusitupa, M
AU - Kolb, H
AU - Laakso, M
AU - Tuomilehto, J
AU - Finnish Diabetes Prevention Study
N1 - © J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York.
PY - 2010/11
Y1 - 2010/11
N2 - Physical activity exerts anti-inflammatory effects, but genetic variation may modify its influence. In particular, the rs1800629 single-nucleotide polymorphism (SNP) in the tumor necrosis factor ( TNF) gene and the rs1800795 SNP in the interleukin-6 ( IL6) gene have been found to modify the effect of exercise training on circulating levels of C-reactive protein (CRP) and IL-6, respectively. We assessed whether rs1800629 and rs1800795 modified the effect of moderate-to-vigorous physical activity on changes in serum levels of high-sensitivity CRP and IL-6 in the Finnish Diabetes Prevention Study (DPS). Genotype and 1-year data on changes in physical activity, serum CRP and IL-6 were available for 390 overweight subjects with impaired glucose tolerance. The rs1800629 SNP in TNF interacted with the 1-year change in moderate-to-vigorous physical activity on changes in CRP among those who had high (≥3 mg/L) baseline CRP levels ( P = 0.034 for interaction). Carriers of the GG genotype showed a greater decrease in CRP with increasing physical activity than the individuals with the A allele. No interaction between the rs1800795 SNP in IL6 and changes in moderate-to-vigorous physical activity on the 1-year change in serum IL-6 was found. In conclusion, the rs1800629 SNP in the TNF gene may modify the effect of moderate-to-vigorous physical activity on serum levels of CRP.
AB - Physical activity exerts anti-inflammatory effects, but genetic variation may modify its influence. In particular, the rs1800629 single-nucleotide polymorphism (SNP) in the tumor necrosis factor ( TNF) gene and the rs1800795 SNP in the interleukin-6 ( IL6) gene have been found to modify the effect of exercise training on circulating levels of C-reactive protein (CRP) and IL-6, respectively. We assessed whether rs1800629 and rs1800795 modified the effect of moderate-to-vigorous physical activity on changes in serum levels of high-sensitivity CRP and IL-6 in the Finnish Diabetes Prevention Study (DPS). Genotype and 1-year data on changes in physical activity, serum CRP and IL-6 were available for 390 overweight subjects with impaired glucose tolerance. The rs1800629 SNP in TNF interacted with the 1-year change in moderate-to-vigorous physical activity on changes in CRP among those who had high (≥3 mg/L) baseline CRP levels ( P = 0.034 for interaction). Carriers of the GG genotype showed a greater decrease in CRP with increasing physical activity than the individuals with the A allele. No interaction between the rs1800795 SNP in IL6 and changes in moderate-to-vigorous physical activity on the 1-year change in serum IL-6 was found. In conclusion, the rs1800629 SNP in the TNF gene may modify the effect of moderate-to-vigorous physical activity on serum levels of CRP.
KW - C-Reactive Protein
KW - Diabetes Mellitus, Type 2
KW - Female
KW - Finland
KW - Genetic Association Studies
KW - Glucose Intolerance
KW - Humans
KW - Interleukin-6
KW - Male
KW - Motor Activity
KW - Overweight
KW - Polymorphism, Single Nucleotide
KW - Promoter Regions, Genetic
KW - Time Factors
KW - Tumor Necrosis Factor-alpha
U2 - 10.1055/s-0030-1249686
DO - 10.1055/s-0030-1249686
M3 - Journal article
C2 - 20361391
VL - 118
SP - 757
EP - 759
JO - Experimental and Clinical Endocrinology and Diabetes
JF - Experimental and Clinical Endocrinology and Diabetes
SN - 0947-7349
IS - 10
ER -
ID: 46280175